Abstract
Environmental factors play an important role in the development of cancer. Tea, one of the most popular beverages in the world, has shown to have anti-cancer effects as well as have protective effects against cancer development. Recent studies have shown that components present in tea could activate the immune system, particularly γδ T cells, which is an important component of both innate and adaptive immune system. As a first line of defense against tumors, the activation of immune system is important to provide necessary preventive measures against tumor. In this chapter, we focus on the mechanism of γδ T cell-mediated recognition of antigens, and delineate the mechanisms, by which tea product can activate γδ T cells to facilitate cancer prevention activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams EJ, Chien YH, Garcia KC (2005) Structure of a gamma delta T cell receptor in complex with the nonclassical MHC T22. Science 308:227–231
Bahram S, Bresnahan M, Geraghty DE, Spies T (1994) A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 91:6259–6263
Begley M, Gahan CGM, Kollas AK, Hintz M, Hill C, Jomaa H, Eberl M (2004) The interplay between classical and alternative isoprenoid biosynthesis controls gamma delta T cell bioactivity of Listeria monocytogenes. FEBS Lett 561:99–104
Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G (2000) Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 373:231–241
Block G, Patterson B, Subar A (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18:1–29
Bonneville M, Scotet E (2006) Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol 18:539–546
Born WK, Reardon CL, O’Brien RL (2006) The function of gammadelta T cells in innate immunity. Curr Opin Immunol 18:31–38
Brandes M, Willimann K, Moser B (2005) Professional antigen-presentation function by human gammadelta T Cells. Science 309:264–268
Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD (2006) IFN-dependent down-regulation of the NKG2D ligand H60 on tumors. J Immunol 176:905–913
Bukowski JF, Percival SS (2008) L-theanine intervention enhances human gammadeltaT lymphocyte function. Nutr Rev 66:96–102
Bukowski JF, Morita CT, Brenner MB (1999) Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 11:57–65
Cao W, He W (2005) The recognition pattern of gammadelta T cells. Front Biosci 10:2676–2700
Castriconi R, Dondero A, Negri F, Bellora F, Nozza P, Carnemolla B, Raso A, Moretta L, Moretta A, Bottino C (2007) Both CD133(+) and CD133(−) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity. Eur J Immunol 37:3190–3196
Chien YH, Konigshofer Y (2007) Antigen recognition by gammadelta T cells. Immunol Rev 215:46–58
Chien YH, Jores R, Crowley MP (1996) Recognition by gamma/delta T cells. Annu Rev Immunol 14:511–532
Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123–133
Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T, Bukowski JF (2001a) MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 15:83–93
Das H, Wang L, Kamath A, Bukowski JF (2001b) Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates. Blood 98:1616–1618
Das H, Sugita M, Brenner MB (2004) Mechanisms of Vdelta1 gammadelta T cell activation by microbial components. J Immunol 172:6578–6586
Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191–1308
Evans S, Dizeyi N, Abrahamsson PA, Persson J (2009) The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models. Anticancer Res 29:3917–3924
Favier B, Espinosa E, Tabiasco J, Dos Santos C, Bonneville M, Valitutti S, Fournie JJ (2003) Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes. J Immunol 171:5027–5033
Fisch P, Moris A, Rammensee HG, Handgretinger R (2000) Inhibitory MHC class I receptors on gammadelta T cells in tumour immunity and autoimmunity. Immunol Today 21:187–191
Fleisch H (2002) Development of bisphosphonates. Breast Cancer Res 4:30–34
Friese MA, Platten M, Lutz SZ, Naumann U, Aulwurm S, Bischof F, Buhring HJ, Dichgans J, Rammensee HG, Steinle A et al (2003) MICA/NKG2D-mediated immunogene therapy of experimental gliomas. Cancer Res 63:8996–9006
Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G (2003) Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 197:163–168
Gomes AQ, Martins DS, Silva-Santos B (2010) Targeting gammadelta T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Cancer Res 70:10024–10027
Graff JC, Jutila MA (2007) Differential regulation of CD11b on gammadelta T cells and monocytes in response to unripe apple polyphenols. J Leukoc Biol 82:603–607
Green AE, Lissina A, Hutchinson SL, Hewitt RE, Temple B, James D, Boulter JM, Price DA, Sewell AK (2004) Recognition of nonpeptide antigens by human V gamma 9 V delta 2 T cells requires contact with cells of human origin. Clin Exp Immunol 136:472–482
Groh V, Steinle A, Bauer S, Spies T (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279:1737–1740
Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T (1999) Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A 96:6879–6884
Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T (2001) Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2:255–260
Halary F, Fournie JJ, Bonneville M (1999) Activation and control of self-reactive gammadelta T cells. Microbes Infect 1:247–253
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Holtmeier W, Kabelitz D (2005) gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy 86:151–183
Hosking D (2006) Pharmacological therapy of Paget’s and other metabolic bone diseases. Bone 38:S3–S7
Jomaa H, Feurle J, Luhs K, Kunzmann V, Tony HP, Herderich M, Wilhelm M (1999) Vgamma9/Vdelta2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis. FEMS Immunol Med Microbiol 25:371–378
Kabelitz D, Wesch D, He W (2007) Perspectives of gammadelta T cells in tumor immunology. Cancer Res 67:5–8
Kamath AB, Wang L, Das H, Li L, Reinhold VN, Bukowski JF (2003) Antigens in tea-beverage prime human Vgamma 2Vdelta 2T cells in vitro and in vivo for memory and nonmemory antibacterial cytokine responses. Proc Natl Acad Sci U S A 100:6009–6014
Kato Y, Tanaka Y, Tanaka H, Yamashita S, Minato N (2003) Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate. J Immunol 170:3608–3613
Khan N, Mukhtar H (2010) Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev 29:435–445
Khan N, Afaq F, Mukhtar H (2008) Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 10:475–510
Kubin M, Cassiano L, Chalupny J, Chin W, Cosman D, Fanslow W, Mullberg J, Rousseau AM, Ulrich D, Armitage R (2001) ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur J Immunol 31:1428–1437
Kunzmann V, Bauer E, Wilhelm M (1999) Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 340:737–738
Li H, Lebedeva MI, Llera AS, Fields BA, Brenner MB, Mariuzza RA (1998) Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor. Nature 391:502–506
Maeurer MJ, Martin D, Walter W, Liu K, Zitvogel L, Halusczcak K, Rabinowich H, Duquesnoy R, Storkus W, Lotze MT (1996) Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med 183:1681–1696
McVay LD, Carding SR (1999) Generation of human gammadelta T-cell repertoires. Crit Rev Immunol 19:431–460
Mitchell SC, Zhang AQ, Smith RL (2000) Ethylamine in human urine. Clin Chim Acta 302:69–78
Mookerjee-Basu J, Vantourout P, Martinez LO, Perret B, Collet X, Perigaud C, Peyrottes S, Champagne E (2010) F1-adenosine triphosphatase displays properties characteristic of an antigen presentation molecule for Vgamma9Vdelta2 T cells. J Immunol 184:6920–6928
Morita CT, Jin CG, Sarikonda G, Wang H (2007) Nonpeptide antigens, presentation mechanisms, and immunological memory of human V gamma 2 V delta 2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 215:59–76
Narazaki H, Watari E, Shimizu M, Owaki A, Das H, Fukunaga Y, Takahashi H, Sugita M (2003) Perforin-dependent killing of tumor cells by Vgamma1Vdelta1-bearing T-cells. Immunol Lett 86:113–119
Nausch N, Cerwenka A (2008) NKG2D ligands in tumor immunity. Oncogene 27:5944–5958
Nishimura H, Yajima T, Kagimoto Y, Ohata M, Watase T, Kishihara K, Goshima F, Nishiyama Y, Yoshikai Y (2004) Intraepithelial gamma delta T cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type. J Virol 78:4927–4930
Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC (2008) Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 88:979–985
Ogawa T, Tsuji-Kawahara S, Yuasa T, Kinoshita S, Chikaishi T, Takamura S, Matsumura H, Seya T, Saga T, Miyazawa M (2011) Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions in vivo. J Virol 85:5423–5435
Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L et al (2002) Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62:6178–6186
Percival SS, Bukowski JF, Milner J (2008) Bioactive food components that enhance gammadelta T cell function may play a role in cancer prevention. J Nutr 138:1–4
Pereira P, Boucontet L (2004) Rates of recombination and chain pair biases greatly influence the primary gammadelta TCR repertoire in the thymus of adult mice. J Immunol 173:3261–3270
Perry CM, Figgitt DP (2004) Zoledronic acid – A review of its use in patients with advanced cancer. Drugs 64:1197–1211
Poggi A, Venturino C, Catellani S, Clavio M, Miglino M, Gobbi M, Steinle A, Ghia P, Stella S, Caligaris-Cappio F et al (2004) Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. Cancer Res 64:9172–9179
Raspollini MR, Castiglione F, Rossi Degl’innocenti D, Amunni G, Villanucci A, Garbini F, Baroni G, Taddei GL (2005) Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma. Ann Oncol 16:590–596
Raulet DH (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3:781–790
Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T (2005) Activation of V gamma 9V delta 2T cells by NKG2D. J Immunol 175:2144–2151
Rock EP, Sibbald PR, Davis MM, Chien YH (1994) CDR3 length in antigen-specific immune receptors. J Exp Med 179:323–328
Rowe CA, Nantz MP, Bukowski JF, Percival SS (2007) Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gamma, delta T cell function: a randomized, double-blind, placebo-controlled study. J Am Coll Nutr 26:445–452
Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG, Steinle A (2003) Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102:1389–1396
Sanders JM, Ghosh S, Chan JM, Meints G, Wang H, Raker AM, Song Y, Colantino A, Burzynska A, Kafarski P et al (2004) Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates. J Med Chem 47:375–384
Scotet E, Martinez LO, Grant E, Barbaras R, Jeno P, Guiraud M, Monsarrat B, Saulquin X, Maillet S, Esteve JP et al (2005) Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 22:71–80
Shin S, El-Diwany R, Schaffert S, Adams EJ, Garcia KC, Pereira P, Chien YH (2005) Antigen recognition determinants of gamma delta T cell receptors. Science 308:252–255
Stearns ME, Amatangelo MD, Varma D, Sell C, Goodyear SM (2010) Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice. Am J Pathol 177:3169–3179
Strong RK (2002) Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer. Mol Immunol 38:1029–1037
Thedrez A, Sabourin C, Gertner J, Devilder MC, Allain-Maillet S, Fournie JJ, Scotet E, Bonneville M (2007) Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? Immunol Rev 215:123–135
Thompson K, Rojas-Navea J, Rogers MJ (2006) Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood 107:651–654
Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A et al (2009) Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila) 2:931–941
Tsuge H, Sano S, Hayakawa T, Kakuda T, Unno T (2003) Theanine, gamma-glutamylethylamide, is metabolized by renal phosphate-independent glutaminase. Bba-Gen Subj 1620:47–53
Vetter CS, Groh V, thor Straten P, Spies T, Brocker EB, Becker JC (2002) Expression of stress-induced MHC class I related chain molecules on human melanoma. J Invest Dermatol 118:600–605
Viey E, Fromont G, Escudier B, Morel Y, Da Rocha S, Chouaib S, Caignard A (2005) Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J Immunol 174:1338–1347
Wang L, Das H, Kamath A, Bukowski JF (2001) Human V gamma 2V delta 2T cells produce IFN-gamma and TNF-alpha with an on/off/on cycling pattern in response to live bacterial products. J Immunol 167:6195–6201
Watson NFS, Spendlovel I, Madjd Z, McGilvray R, Green AR, Ellis IO, Scholefield JH, Durrant LG (2006) Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. Int J Cancer 118:1445–1452
Wu J, Groh V, Spies T (2002) T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells. J Immunol 169:1236–1240
Xu JL, Davis MM (2000) Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13:37–45
Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203–213
Zhao J, Huang J, Chen H, Cui L, He W (2006) Vdelta1 T cell receptor binds specifically to MHC I chain related A: molecular and biochemical evidences. Biochem Biophys Res Commun 339:232–240
Zhou JR, Yu L, Zhong Y, Blackburn GL (2003) Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 133:516–521
Acknowledgements
This work was supported in part by National Institutes of Health grants, K01 AR054114 (NIAMS), SBIR R44 HL092706-01 (NHLBI), R21 CA143787 (NCI) and The Ohio State University start-up fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Lu, J., Pompili, V.J., Das, H. (2012). γδ T Cells, Tea and Cancer. In: Shankar, S., Srivastava, R. (eds) Nutrition, Diet and Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2923-0_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-2923-0_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2922-3
Online ISBN: 978-94-007-2923-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)